Via® Graft is a viable allogenic bone allograft, in full compliance with all FDA guidelines regarding human cells, tissues and cellular tissue-based products, and is intended for use in bone remodeling. Via Graft contains cellular and bone scaffold components. The bone scaffold is comprised of a proprietary blend of mineralized microparticulate cortical, cancellous and demineralized cortical allograft bone in optimum particle sizes ranging from 100-300 microns. It is offered in 1cc, 2.5cc, 5.0cc, and 10 cc sizes. Via Graft bone scaffold and cell mixture allow for tight packing of defect with a cohesive wet sand consistency.
Via Graft is prepared with a novel DMSO-free cryoprotectant, which preserves a cell population that includes marrow-isolated adult multilineage inducible (MIAMI) cells. These primitive cells provide properties that, in combination with the osteoconductive, osteoinductive, and osteogenic elements of the graft, enhance the patient’s innate healing process.
Via Graft provides key elements ideal for bone repair:
- Three dimensional osteoconductive bone scaffold
- Demineralized bone scaffold with osteoinductive potential
Key Features and Benefits include:
- Novel, DMSO-free cryoprotectant that is effective and safe to implant
- Convenient handling and preparation in the OR
- 2-year shelf life
- Preparation time on back table is less than 20 minutes
Potential Applications include:
- Upper Extremity
- Foot and Ankle
- Oral and Maxillofacial
- Orthopaedic Oncology